What is LOPJLB’s current signal on INM?

LOPJLB’s latest quantitative signal on InMed Pharmaceuticals Inc. (INM) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is INM in?

InMed Pharmaceuticals Inc. (INM) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does InMed Pharmaceuticals Inc. (INM) do?

InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary product, INM-755, is a cannabinol-infused topical cream that is currently progressing through its second Phase I clinical trial for the management of epidermolysis bullosa. Beyond this lead candid…